BlackRock’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,271
| Closed | -$37K | – | 5368 |
|
|
2024
Q2 | $37K | Sell |
4,271
-440
| -9% | -$3.9K | ﹤0.01% | 4915 |
|
|
2024
Q1 | $41.2K | Sell |
4,711
-5,721
| -55% | -$47.2K | ﹤0.01% | 4913 |
|
|
2023
Q4 | $77.7K | Buy |
10,432
+5,506
| +112% | +$35.9K | ﹤0.01% | 4874 |
|
|
2023
Q3 | $28.4K | Sell |
4,926
-161
| -3% | -$1.1K | ﹤0.01% | 5093 |
|
|
2023
Q2 | $36.6K | Sell |
5,087
-411
| -7% | -$2.98K | ﹤0.01% | 5120 |
|
|
2023
Q1 | $40.4K | Sell |
5,498
-966
| -15% | -$8.21K | ﹤0.01% | 5157 |
|
|
2022
Q4 | $43.2K | Sell |
6,464
-17
| -0.3% | -$149 | ﹤0.01% | 5261 |
|
|
2022
Q3 | $65K | Sell |
6,481
-357
| -5% | -$4.51K | ﹤0.01% | 5301 |
|
|
2022
Q2 | $84K | Sell |
6,838
-47,895
| -88% | -$757K | ﹤0.01% | 5284 |
|
|
2022
Q1 | $1.16M | Buy |
54,733
+331
| +0.6% | +$11.5K | ﹤0.01% | 4618 |
|
|
2021
Q4 | $3.27M | Buy |
54,402
+193
| +0.4% | +$14.4K | ﹤0.01% | 4191 |
|
|
2021
Q3 | $5.08M | Buy |
54,209
+389
| +0.7% | +$51.8K | ﹤0.01% | 3951 |
|
|
2021
Q2 | $8.9M | Buy |
53,820
+5,660
| +12% | +$961K | ﹤0.01% | 3679 |
|
|
2021
Q1 | $9.28M | Buy |
+48,160
| New | +$12M | ﹤0.01% | 3616 |
|